I'll be a bit clearer here. When claiming IP you need to claim...

I'll be a bit clearer here.

When claiming IP you need to claim something novel (first time in the world) or an inventive step (a recipe).

When we came to cannabis & MDMA (non-synthetic) this is NOT something new to the world and cannot be IP protected. (its nature - you didn't invent it)

However, you can IP protect 'a recipe' in this case a recipe dosing method (how much, how often) for a specific indication. But you still need to make the cake! (in the case of drug development this cake takes a long time).

Now when we come to synthetic that's where we also can patent 'something novel' and new in the world for the first time. This is why we have gone synthetic as both sides, the product it is made of and the recipe of 'dosing' 'how much' ' when to add it' can be IP protected

This is why we have gone synthetics (on top of the purity and production benefits). The MDMA analogs are owned by the university (and we have exclusive rights) can't remember 100% about the synthetic cannabis.

There is nothing special about GW Pharma product that sold for 7Billion - its some CBD in grape seed oil. And for the dosing well they just went through the motion and were the first to make the cake that worked.

Now imagine what they are going to pay for this baby when both sides are IP protected, and it has a better (recipe) dosing profiles, and delivery method (not oil) - oil isnt very shelf stabe either.

EMD-RX7 move the f**K over GW and MindMed (usa) EMD is #2 in the world.